Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
E. Boutsikou, P. Zarogoulidis, K. Porpodis, D. Latsios, M. Kipourou, K. Zarogoulidis (Thessaloniki, Greece). The role of second line chemotherapy in small cell lung cancer: A retrospective analysis. Eur Respir J 2013; 42: Suppl. 57, 376

Member's Comments

No comment yet.

Related content which might interest you: Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015 Electrospray-mediated local chemotherapy of lung carcinoma in mice Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 A phase III randomised trial testing chemotherapy in extensive small-cell lung cancer (SCLC) Source: International Congress 2016 – Therapeutic trials in lung cancer Year: 2016 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Algorithm of preoperative N-staging of non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Predictors of lung cancer patients delay time in Serbia - a cross-sectional study Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 PIWI proteins as prognostic markers in non small cell lung cancer Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Sleeve lung resection for non-small cell lung cancer after induction therapy: A safe method Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Lung cancer risk prediction model based on data of the SOS trial (single center non-randomized lung cancer early detection trial) Source: International Congress 2014 – Risk assessment and tracheal reconstructions Year: 2014 Safety and efficacy of erlotinib in patients with squamous cell lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Treatment of advanced non-small cell lung cancer with trofosfamide Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Surgical treatment outcomes on early-stages of non-small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Segmentectomy for second lung cancer after lobectomy Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 Risk factors for prolonged postoperative air leak-a retrospective analysis of 853 partial lung resections for non-small cell lung cancer Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013 ALK/EML4 translocation in non-squamous NSCLC and their predictors Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015